Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA GSK PHARMA ASTRAZENECA PHARMA/
GSK PHARMA
 
P/E (TTM) x 95.5 62.2 153.4% View Chart
P/BV x 22.7 18.9 120.2% View Chart
Dividend Yield % 0.3 1.6 18.3%  

Financials

 ASTRAZENECA PHARMA   GSK PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
GSK PHARMA
Mar-23
ASTRAZENECA PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3,6201,684 215.0%   
Low Rs2,4381,231 198.1%   
Sales per share (Unadj.) Rs401.2191.9 209.0%  
Earnings per share (Unadj.) Rs39.735.9 110.7%  
Cash flow per share (Unadj.) Rs46.239.8 116.3%  
Dividends per share (Unadj.) Rs16.0032.00 50.0%  
Avg Dividend yield %0.52.2 24.1%  
Book value per share (Unadj.) Rs234.4102.9 227.9%  
Shares outstanding (eoy) m25.00169.41 14.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.57.6 99.4%   
Avg P/E ratio x76.340.6 187.7%  
P/CF ratio (eoy) x65.536.7 178.8%  
Price / Book Value ratio x12.914.2 91.2%  
Dividend payout %40.389.2 45.2%   
Avg Mkt Cap Rs m75,718246,858 30.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5915,950 43.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03032,517 30.8%  
Other income Rs m2611,007 25.9%   
Total revenues Rs m10,29133,524 30.7%   
Gross profit Rs m1,2498,033 15.5%  
Depreciation Rs m163658 24.7%   
Interest Rs m618 34.8%   
Profit before tax Rs m1,3418,364 16.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3482,288 15.2%   
Profit after tax Rs m9936,076 16.3%  
Gross profit margin %12.524.7 50.4%  
Effective tax rate %26.027.4 94.9%   
Net profit margin %9.918.7 53.0%  
BALANCE SHEET DATA
Current assets Rs m9,35924,943 37.5%   
Current liabilities Rs m4,84413,264 36.5%   
Net working cap to sales %45.035.9 125.3%  
Current ratio x1.91.9 102.7%  
Inventory Days Days4997 50.8%  
Debtors Days Days39216 18.1%  
Net fixed assets Rs m2,0616,988 29.5%   
Share capital Rs m501,694 3.0%   
"Free" reserves Rs m5,81115,735 36.9%   
Net worth Rs m5,86117,430 33.6%   
Long term debt Rs m00-   
Total assets Rs m11,42131,930 35.8%  
Interest coverage x213.9462.6 46.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.0 86.2%   
Return on assets %8.719.1 45.8%  
Return on equity %16.934.9 48.6%  
Return on capital %23.048.1 47.8%  
Exports to sales %00-   
Imports to sales %37.448.1 77.7%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,74715,630 24.0%   
Fx inflow Rs m6121,622 37.7%   
Fx outflow Rs m3,74715,630 24.0%   
Net fx Rs m-3,135-14,008 22.4%   
CASH FLOW
From Operations Rs m5834,842 12.0%  
From Investments Rs m1818,079 2.2%  
From Financial Activity Rs m-245-15,433 1.6%  
Net Cashflow Rs m519-2,512 -20.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 5.4 11.6 46.8%  
FIIs % 2.7 2.9 90.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   29,032 114,663 25.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs GSK Pharma Share Price Performance

Period ASTRAZENECA PHARMA GSK Pharma S&P BSE HEALTHCARE
1-Day 0.01% 3.26% 1.18%
1-Month -3.61% -9.77% -0.75%
1-Year 59.20% 52.63% 61.82%
3-Year CAGR 20.50% 10.89% 18.16%
5-Year CAGR 22.18% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.